Authors
Loading...
Multimodal transformer improves survival prediction in HER2-positive breast cancer, highlighting tumor heterogeneity.
Li et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: